|
Volumn 429, Issue 6992, 2004, Pages 587-
|
Gene therapists hopeful as trials resume with childhood disease
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHILDHOOD DISEASE;
CLINICAL RESEARCH;
COMBINED IMMUNODEFICIENCY;
FOOD AND DRUG ADMINISTRATION;
GENE;
GENE THERAPY;
HUMAN;
LMO2 GENE;
MEDICAL SPECIALIST;
NOTE;
PRIORITY JOURNAL;
UNITED STATES;
X CHROMOSOME LINKED DISORDER;
ARTICLE;
CHILD;
CLINICAL TRIAL;
FRANCE;
GENETIC LINKAGE;
GENETICS;
INFANT;
LEGAL ASPECT;
LEUKEMIA;
RISK;
X CHROMOSOME;
DNA BINDING PROTEIN;
LMO2 PROTEIN, HUMAN;
METALLOPROTEIN;
CHILD;
CHROMOSOMES, HUMAN, X;
CLINICAL TRIALS;
DNA-BINDING PROTEINS;
FRANCE;
GENE THERAPY;
HUMANS;
INFANT;
LEUKEMIA;
LINKAGE (GENETICS);
METALLOPROTEINS;
RISK;
SEVERE COMBINED IMMUNODEFICIENCY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 2942559016
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/429587a Document Type: Note |
Times cited : (7)
|
References (0)
|